首页> 外文期刊>BMC Public Health >Effectiveness of peer support for improving glycaemic control in patients with type 2 diabetes: a meta-analysis of randomized controlled trials
【24h】

Effectiveness of peer support for improving glycaemic control in patients with type 2 diabetes: a meta-analysis of randomized controlled trials

机译:对2型糖尿病患者改善血糖控制的同伴支持的有效性:随机对照试验的荟萃分析

获取原文
           

摘要

Background To assess the effects of peer support at improving glycemic control in patients with type 2 diabetes. Methods Relevant electronic databases were sought for this investigation up to Dec 2014. Randomized controlled trials involving patients with type 2 diabetes that evaluated the effect of peer support on glycated hemoglobin (HbA1c) concentrations were included. The pooled mean differences (MD) between intervention and control groups with 95% confidence interval (CI) were calculated using random-effects model. The Cochrane Collaboration’s tool was used to assess the risk of bias. Results Thirteen randomized controlled trials met the inclusion criteria. Peer support resulted in a significant reduction in HbA1c (MD ?0.57 [95% CI: ?0.78 to ?0.36]). Programs with moderate or high frequency of contact showed a significant reduction in HbA1c levels (MD ?0.52 [95% CI: ?0.60 to ?0.44] and ?0.75 [95% CI: ?1.21 to ?0.29], respectively), whereas programs with low frequency of contact showed no significant reduction (MD ?0.32 [95% CI: ?0.74 to 0.09]). The reduction in HbA1c were greater among patients with a baseline HbA1c?≥?8.5% (MD ?0.78 [95% CI: ?1.06 to ?0.51]) and between 7.5?~?8.5% (MD ?0.76 [95% CI: ?1.05 to ?0.47]), than patients with HbA1c?Conclusions Peer support had a significant impact on HbA1c levels among patients with type 2 diabetes. Priority should be given to programs with moderate or high frequency of contact for target patients with poor glycemic control rather than programs with low frequency of contact that target the overall population of patients.
机译:背景技术评估同伴支持对2型糖尿病患者血糖控制改善血糖控制的影响。方法采取相关的电子数据库,达到2014年12月。涉及评价对同糖尿病对糖尿病血红蛋白(HBA1C)浓度的2型糖尿病患者的随机对照试验。使用随机效应模型计算干预和对照组之间的汇总平均差异(MD),具有95%置信区间(CI)计算。 Cochrane协作的工具用于评估偏差的风险。结果十三次随机对照试验符合纳入标准。对等支持导致HBA1C的显着降低(MD?0.57 [95%CI:0.78至0.36])。具有中等或高频率接触频率的程序显示出HBA1C水平显着降低(MD?0.52 [95%CI:0.60至0.44]和?0.75分别[95%CI:?1.21至0.29],而计划触点频率低显示出没有显着的减少(MD?0.32 [95%CI:0.74至0.09])。基线HBA1C的患者中HBA1C的还原在≥1.≤X≤8.5%(MD?0.78 [95%CI:α1.06至0.51])和7.5?〜8.5%(MD?0.76 [95%CI:比HBA1C患者的1.05至0.47]),结论同伴支持对2型糖尿病患者的HBA 1c 水平产生显着影响。优先考虑具有适度或高频率的血糖控制患者的中等或高频接触频率,而不是靶向患者总体群体的低频率的程序。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号